Table 4. Figure 5 electrophysiological measurements segregated by sex.
| Measure | WT | FGF14−/− | Double KO | |||
|---|---|---|---|---|---|---|
| M (n = 5) | F (n = 2) | M (n = 0) | F (n = 6) | M (n = 0) | F (n = 9) | |
| Itransdecay τslow (ms) control | 13.7 ± 1.5 | 16.4 ± 3.1 | 10.5 ± 0.41 | 11.3 ± 0.42 | ||
| Itransdecay τslow (ms) ATX | 22 ± 0.6 | 24.1 ± 1.7 | 18.1 ± 1.1 | 17.7 ± 0.44 | ||
| V at 50% (mV) control | −55 ± 1.1 | −54.1 ± 3.3 | −57.9 ± 1 | −58.5 ± 1.3 | ||
| V at 50% (mV) ATX | −57.7 ± 1.1 | −56.1 ± 4.3 | −58.6 ± 1.2 | −59.7 ± 1.2 | ||
| Relative Iss (%) control | 0.8 ± 0.13 | 0.35 ± 0.1 | 0.42 ± 0.1 | 0.62 ± 0.17 | ||
| Relative Iss (%) ATX | 25.9 ± 1.4 | 27.9 ± 4.4 | 11.2 ± 1.5 | 11.8 ± 1 | ||
| Relative Irsg (%) control | 4.9 ± 0.48 | 5.03 ± 0.23 | 2.79 ± 0.31 | 3.78 ± 0.42 | ||
| Relative Irsg (%) ATX | 49.6 ± 1.2 | 59.2 ± 4.7 | 30.9 ± 2.6 | 33.9 ± 1 | ||
| Irsg–Iss (%) control | 4.11 ± 0.37 | 4.68 ± 0.14 | 2.37 ± 0.27 | 3.16 ± 0.3 | ||
| Irsg–Iss (%) ATX | 23.8 ± 0.89 | 27 ± 0.3 | 19.7 ± 1.3 | 22.1 ± 0.38 | ||